Skip to main content

Day: May 1, 2020

High Arctic Continues Outstanding Safety Performance and Updates Cost Initiatives

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES.  ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWCALGARY, Alberta, April 30, 2020 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (“High Arctic”, the “Corporation” or “We”) is pleased to report on outstanding operational safety performance and progress made on previously announced cost reduction measures. On April 16, 2020 the Corporation’s Production Services operation with our major customer at Cold Lake, Alberta reached the world-class milestone of seven (7) years Total Recordable Incident Free.  It is our largest single operation with many of the Corporation’s well servicing rigs on contract with a top-tier major customer.  Over the seven years, the team amassed 1.64 million...

Continue reading

Goldquest: Grant of Stock Options

VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) — GoldQuest Mining Corp. (TSXV:GQC, “GoldQuest” or the “Company”) announces that the board of directors of the Company has authorized the grant of an aggregate of 3,400,000 incentive stock options (the “Options”) to directors, officers and employees of the Company, at an exercise price of $0.20 per common share.The Options are exercisable for a five-year period from the date of grant and will vest as follows: ⅓ on the date of grant, ⅓ on the six month anniversary from the date of the grant and ⅓ on the one year anniversary from the date of the grant.The Options are granted pursuant to the Company’s stock option plan, which was most recently approved by shareholders at the Company’s annual general meeting of shareholders held on June 28, 2019.About GoldQuestGoldQuest is...

Continue reading

Annual General Meeting Voting Results

VANCOUVER, British Columbia, April 30, 2020 (GLOBE NEWSWIRE) — Pretium Resources Inc. (TSX/NYSE:PVG) (“Pretivm” or the “Company”) announces the voting results from its Annual General Meeting of shareholders held today (the “Meeting”).  A total of 132,934,862 (71.65%) of Pretivm’s common shares were represented at the Meeting.The seven nominees listed in the management information circular with respect to the Meeting were elected as directors of Pretivm.  Detailed results of the vote for the election of directors are set out below:Number of DirectorsSetting the number of Directors at seven:Election of DirectorsFollowing the Meeting, Pretivm’s Board of Directors appointed Jacques Perron, the Company’s President and Chief Executive Officer, as a director of the Company.Voting results with respect to the other matters at the Meeting,...

Continue reading

Installux : Rapport Financier Annuel 2019

Avis de mise à disposition du rapport financier annuel 2019Le rapport financier annuel 2019 du Groupe Installux est consultable à l’adressesuivante :http://www.worldreginfo.com/rd/idefault.asp?uid=%7b5A3E8E6C-26B0-4842-BE01-95E8548428A5%7dPièce jointeAvis de mise à disposition du rapport financier annuel 2019

Continue reading

Telix Pharmaceuticals submits European marketing authorisation application for prostate cancer imaging product

MELBOURNE, Australia and LIÈGE, Belgium, May 01, 2020 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Limited (ASX: TLX, ‘Telix’, the ‘Company’) today announces that it has submitted a marketing authorisation application (MAA) in Europe for TLX591-CDx (68Ga-PSMA-11 Injection) for the imaging of prostate cancer with Positron Emission Tomography (PET).The submission has been made to the Danish Medicines Agency (DKMA) in its capacity as a reference Competent Authority of a European member state. The DKMA will coordinate and lead the evaluation of Telix’s MAA for TLX591-CDx on behalf of Denmark as well as a selection of European countries, nominated by Telix. These countries reflect the major European markets for Telix’s prostate cancer imaging product.In accordance with the current European Association of Urology (EAU) guidelines on prostate...

Continue reading

TIM PARTICIPAÇÕES S.A.: Filing of annual report on Form 20-F for the year ended in December 31, 2019

RIO DE JANEIRO, Brazil, April 30, 2020 (GLOBE NEWSWIRE) — TIM Participações S.A. (“Company”) (B3:TIMP3) (NYSE:TSU) hereby informs its shareholders and the market in general that it has filed its 2019 annual report (“Form 20-F”) for the calendar year ended December 31, 2019 with the U.S. Securities and Exchange Commission (“SEC”).The Form 20-F is available for download on the Company’s Investor Relations website, www.tim.com.br/ir, and, in addition, shareholders may receive a hard copy of the Form 20-F and the complete financial statements, free of charge, by requesting in the following channels: by telephone (+55 21) 4109-4167 or by email ri@timbrasil.com.br.Any further information regarding the Form 20-F can be obtained by contacting Investor Relations Team and/or Mr. Adrian Calaza, Chief Financial Officer and...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.